Stocktoria

ABVC BIOPHARMA, INC. ABVC

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2004-11-09

ABVC BIOPHARMA, INC. statistics & valuation

P / B3.0×
Net margin-2671.8%
Return on capital-48%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-87184.20% -560.50% -2193.10% -3608.50% -1693.50% -5109.30% -962.10% -2671.80% 2017201720182019202020212022202320242025
Gross margin (%)
-2563.60% 97.10% 96.10% 98.60% 70.50% -98.10% 99.90% 2017201720182019202020212022202320242025
Operating margin (%)
-40031.10% -492.90% -1760.90% -3290.10% -1558.50% -4439.20% -923.30% -2416.00% 2017201720182019202020212022202320242025
Return on equity (%)
-308.10% -144.70% -507.50% -501.10% -399.90% -59.50% 2017201720182019202020212022202320242025
Shares outstanding
528.9M 528.9M 529.2M 48.2M 60.4M 62.0M 8.1M 19.6M 21.8M 25.1M 2017201720182019202020212022202320242025
Net debt ($)
2017201720182019202020212022202320242025
Share buybacks ($)
2017201720182019202020212022202320242025
Return on assets (%)
-147.80% -160.50% -102.10% -56.80% -91.30% -93.70% -171.40% -100.00% -65.00% -37.50% 2017201720182019202020212022202320242025
Free cash flow margin (%)
-2140.30% -775.20% -2760.60% 2017201720182019202020212022202320242025
Debt / equity (×)
2017201720182019202020212022202320242025
EPS ($)
-$0.01 -$0.01 -$0.01 -$0.20 -$0.21 -$2.10 -$0.73 -$0.27 -$0.39 2017201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017
Gross margin99.9%-98.1%70.5%98.6%96.1%97.1%-2563.6%
Operating margin-2416.0%-923.3%-4439.2%-1558.5%-3290.1%-1760.9%-492.9%-40031.1%
Net margin-2671.8%-962.1%-5109.3%-1693.5%-3608.5%-2193.1%-560.5%-87184.2%
FCF margin-2760.6%-775.2%-2140.3%
Return on assets-37.5%-65.0%-100.0%-171.4%-93.7%-91.3%-56.8%-102.1%-160.5%-147.8%
Return on equity-59.5%-399.9%-501.1%-507.5%-144.7%-308.1%2605.4%107.2%241.5%292.3%
Current ratio0.410.330.270.542.071.270.130.050.60

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.